Verity Pharmaceuticals Inc. – Trademark Portfolio
Entity Type: 03
Verity Pharmaceuticals Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include IVOZFO and V VERITY PHARMACEUTICALS. The owner is based in Mississauga, Ontario.
2560 Matheson Blvd. East, Suite 220
Mississauga, Ontario L4W4Y9 , CA
Showing of trademarks Trademarks
Trademark Classifications
Verity Pharmaceuticals Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Verity Pharmaceuticals Inc. have?
Verity Pharmaceuticals Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned.
What trademark classes does Verity Pharmaceuticals Inc. file in?
Verity Pharmaceuticals Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Verity Pharmaceuticals Inc.'s most well-known trademarks?
Verity Pharmaceuticals Inc.'s registered trademark portfolio includes well-known marks such as IVOZFO and V VERITY PHARMACEUTICALS. These are among 2 currently registered trademarks in the portfolio.
What is Verity Pharmaceuticals Inc.'s trademark registration success rate?
Verity Pharmaceuticals Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.